Your Article Summary
See Latest ArticlesImmunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 06/15/09
Nikitakis NG et al. - The data indicate an almost universal expression of activated Stat3 and survivin in benign and malignant SGTs. Considering the well established proliferative and antiapoptotic properties of these molecules and their functional interrelationship, selective targeting techniques against Stat3 and/or survivin may represent promising therapeutic strategies against neoplasms of salivary gland origin.
Today in Salivary Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09
Clinicopathologic similarities between Mikulicz disease and Kuttner tumor
American Journal of Otolaryngology, 11/04/09